This presents a different oncogenic role compared to E-cadherin: it alters adherens junctions, interferes with junction formation in aggregating cells, and stimulates the activity of matrix metalloproteinases, disintegrins, and other metalloproteinases, leading to changes in extracellular matrix conformation, thereby favoring the process of tumor invasion [47,50]. Here, CDH1 is linked to neoplasm.